Skip to main content
OpenTrials
Completed

NCT Number: NCT05477602

The Automated Calculation of AF Cycle Length and Complexity Using a Novel EP Recording System

Collect electrophysiological data during atrial fibrillation (AF) ablation procedures to assess the performance of a Signal Complexity Visualization algorithm designed to be integrated into the CathVision ECGenius® System.

Completed

Looking for future studies?

Notify Me

Key information

Age range

21 year–85 year

Sex eligibility

All sexes

Study type

Observational

Primary location

OLV Aalst

Aalst, 9300, Belgium

About this study

A prospective, single-center, feasibility study using the CathVision ECGenius® system and a Signal Complexity Visualization Algorithm during radiofrequency (RF) ablation procedures to treat persistent AF.

Subjects with persistent AF who are indicated to undergo a routine-practice RF ablation may be enrolled in the Study. Intracardiac signals will be passively recorded using the investigational CathVision ECGenius® System in parallel with a commercial (CE Approved) EP recording system. The investigational device will not be used for direct clinical care decisions or therapy.

The validation of the Signal Complexity Visualization Algorithm will be performed offline and retrospectively.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Subjects undergoing RF ablation indicated by the investigator for the treatment of persistent atrial fibrillation.
  • Male or non-pregnant female aged ≥ 21 years.
  • Able and willing to provide written informed consent prior to any clinical investigation related procedure.

Exclusion criteria

  • Current participation in another investigational drug or device study that interferes with this study.
  • Presence of other anatomic or comorbid conditions, or other medical, social, or psychological conditions that, in the investigator's opinion, could limit the subject's ability to participate in the clinical investigation or to comply with follow-up requirements, or impact the scientific soundness of the clinical investigation results.
  • Life expectancy less than 12 month, in the opinion of the Investigator.
  • Subjects who, in the opinion of the investigator, are not candidates for this study.
  • Subjects who, in the opinion of the investigator, are considered part of any vulnerable population.

Treatment and study plan

Cardiac Ablation for the treatment of persistent Atrial Fibrillation

Procedure

Patients undergoing cardiac ablation for the treatment of persistent atrial fibrillation

Other names: Persistent AF Ablation

Primary outcomes

  1. Measurement of AF Cycle Length

    Time frame: One day - day of procedure

    Data collected during the study will be used to test an AF cycle length algorithm

Sponsors and collaborators

Lead sponsor

CathVision ApS

Industry

Registry information

Official study title

The Automated Calculation of AF Cycle Length and Complexity Using a Novel EP Recording System (The CathVision ECGenius System)

Important dates

Study start
2023
Primary completion
2024
Study completion
2024
First posted
Jul 28, 2022
Registry last updated
Jan 30, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.